SMTL ID : 8p64.1

Co-crystal structure of PD-L1 with low molecular weight inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.31 Å

Oligo State

homo-dimer

Ligands

1 x X1Q: ~{N}-[[1-[(~{E})-2-(2-methyl-3-phenyl-phenyl)ethenyl]-1,2,3,4-tetrazol-5-yl]methyl]ethanamine(Non-covalent)

X1Q.1: 20 residues within 4Å: Chain A: F.5, T.6, I.40, Y.42, M.101, I.102, S.103, A.107, D.108, Y.109 Chain B: I.40, Y.42, Q.52, V.54, M.101, I.102, S.103, A.107, D.108, Y.109 10 PLIP interactions: 6 interactions with chain A, 4 interactions with chain B Hydrophobic interactions: A:T.6, A:M.101, A:A.107, A:Y.109, B:I.40, B:M.101, B:A.107 Hydrogen bonds: A:F.5, A:Y.109, B:Q.52

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

van der Straat, R. et al., 1,5-Disubstituted tetrazoles as PD-1/PD-L1 antagonists. Rsc Med Chem (2024)

Release Date

2024-03-06

Peptides

Programmed cell death 1 ligand 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Programmed cell death 1 ligand 1